Evidence map›Paper›PMID 28708126›Full record

Trial reportNutrients2017

The Effect of a 12-Week Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation on Highly-Trained Combat Sports Athletes: A Randomised, Double-Blind, Placebo-Controlled Crossover Study.

Krzysztof Durkalec-Michalski, Jan Jeszka, Tomasz Podgórski

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Frontiers in nutrition · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Review
  18. Prospect of Muscle-Building Supplement HMB in Alzheimer's Disease.Journal of clinical & experimental immunology · 2026
    Article
  19. Review
  20. International society of sports nutrition position stand: β-hydroxy-β-methylbutyrate (HMB).Journal of the International Society of Sports Nutrition · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Krzysztof Durkalec-MichalskiDepartment of Hygiene and Human Nutrition, Poznan University of Life Sciences, 60-624 Poznań, Poland. durkmich@up.poznan.pl.
Jan JeszkaDepartment of Hygiene and Human Nutrition, Poznan University of Life Sciences, 60-624 Poznań, Poland. jeszkaj@up.poznan.pl.
Tomasz PodgórskiDepartment of Biochemistry, Poznan University of Physical Education, 61-871 Poznań, Poland. podgorski@awf.poznan.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to verify the effect of beta-hydroxy-beta-methylbutyrate (HMB) supplementation on physical capacity, body composition and the value of biochemical parameters in highly-trained combat sports athletes. Forty-two males highly-trained in combat sports were subjected to 12 weeks of supplementation with HMB and a placebo in a randomized, placebo controlled, double-blind crossover manner. Over the course of the experiment, aerobic and anaerobic capacity was determined, while analyses were conducted on body composition and levels of creatine kinase, lactate dehydrogenase, testosterone, cortisol and lactate. Following HMB supplementation, fat-free mass increased (

Indexed as

AthletesAdultBiomarkersBody CompositionCreatine KinaseCross-Over StudiesDietary SupplementsDouble-Blind MethodHeart RateHumansHydrocortisoneLactic AcidL-Lactate DehydrogenaseMaleMartial ArtsOxygen Consumptionbeta-hydroxyisovaleric acidBiomarkersCreatine KinaseHydrocortisoneLactic AcidL-Lactate DehydrogenasePlacebosTestosteroneValeratesadaptationbody compositionmaximal oxygen uptakemuscle power indicessportsupplementstraining supportβ-hydroxy-β-methylbutyric acid

Identifiers

PMID28708126
PMCPMC5537867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.